What are the main radiation sources in a nuclear medicine department?

The injected patient is often the dominant source because the patient becomes a distributed gamma emitter, along with the hot lab (generator, vials, syringes, and waste), the dose-administration area, uptake and waiting areas, imaging rooms, restrooms used by injected patients, and decay-in-storage waste. Shielding is organized by room occupancy, distance, activity, and time rather than by the camera alone.

Why does I-131 therapy need more shielding than a Tc-99m imaging room?

I-131 emits a higher-energy 364 keV photon and is administered at much higher activities for therapy, and therapy patients may remain in the room for extended periods. Both the higher energy (larger tenth-value layer) and the higher time-integrated activity increase barrier requirements, so inpatient radioiodine therapy rooms are shielded and evaluated as a distinct, more demanding problem.

Who should design and verify nuclear medicine shielding?

A qualified or board-certified medical physicist prepares or reviews the shielding design and performs a post-construction radiation survey to confirm the installed barriers meet the design goals. Many states and license conditions require a physicist's shielding report before a nuclear medicine facility is approved for clinical use.

Nuclear Medicine Department Shielding Design

Q: Does a conventional nuclear medicine department need lead-lined walls like a PET suite?

Usually far less, and often none. Conventional nuclear medicine runs mostly on Tc-99m, whose 140 keV photons are much less penetrating than the 511 keV annihilation photons in PET. The tenth-value layer of lead at 140 keV is roughly 0.9 mm versus about 17 mm at 511 keV, so equivalent barrier performance needs far less lead. In many conventional departments, distance, layout, and ordinary construction meet the design goals, and lead is reserved for the hot lab, specific adjacencies, or therapy rooms.

Q: How is the required barrier thickness calculated?

The unshielded weekly dose at an occupied point is estimated from the dose-rate constant, the activity present, the distance, and the time and number of patients. The required transmission factor is the weekly design goal divided by the product of the unshielded dose and the occupancy factor, and the barrier thickness follows from the tenth-value layer of the chosen material at the relevant photon energy.

Shielding a nuclear medicine department is a workflow problem before it is a construction problem: the dominant radiation source is usually the injected patient, who becomes a distributed gamma emitter and moves through the hot lab, injection area, uptake room, camera room, restroom, and discharge path over the course of a study. For a conventional department running on technetium-99m, the good news is that 140 keV photons are far less penetrating than the 511 keV annihilation photons of PET, so the tenth-value layer of lead is roughly 0.9 mm at 140 keV versus about 17 mm at 511 keV — which means distance, room layout, and workflow, rather than heavy lead barriers, usually carry the shielding load.¹²

A defensible design still requires explicit evaluation. The physicist estimates the unshielded dose at each occupied point from the dose-rate constant, the activity present, the distance, and the time and patient throughput; compares it to a weekly design goal; and determines whether ordinary construction, added distance, or a modest thickness of lead is needed — then verifies the result with a post-construction survey.¹²³

Introduction

Nuclear medicine shielding differs from both diagnostic x-ray shielding and PET shielding because the source is an unsealed radionuclide distributed in and around patients, not a collimated x-ray beam or a high-energy positron emitter. The design must follow the radiopharmaceutical through the department: from the generator and dose preparation in the hot lab, through injection and uptake, into the imaging room where the patient sits as a distributed 140 keV source, and out through recovery, restrooms, and waste storage.¹⁴

Two features make the conventional (single-photon) case more forgiving than PET. First, the workhorse radionuclide, Tc-99m, emits a 140.5 keV photon — energetic enough to image but soft enough to be attenuated efficiently by modest materials. Second, activities per patient are lower than the high administered activities and long uptake dwell times that make PET barriers thick.¹² The result is that many conventional nuclear medicine departments meet their design goals through layout and distance, reserving lead for the hot lab, specific high-occupancy adjacencies, and — as a separate, more demanding problem — inpatient I-131 therapy rooms.¹⁵

This guide covers the radiation sources, the design goals, the dose-rate constants and tenth-value layers that drive the arithmetic, a worked barrier calculation that shows why conventional rooms rarely need structural lead, the clinical and operational impact of layout decisions, practical optimization tips, the regulatory framework, and the verification that makes a shielding package defensible.

Topic Explanation

What the shielding problem is

Nuclear medicine shielding is the barrier and layout design that keeps dose in occupied areas adjacent to a nuclear medicine department within the applicable design goals. Because the radionuclide is unsealed and travels with the patient, the design is organized by room function, occupancy, distance, activity, and time — not by the footprint of the gamma camera.¹

Key terms used throughout this guide:

Dose-equivalent rate constant ( $Γ$ ) — the dose-equivalent rate at unit distance per unit activity for a given radionuclide, used to convert activity and distance into dose rate.¹
Design goal (P) — the weekly dose limit a barrier is engineered to meet at an occupied point on the far side.
Occupancy factor (T) — the fraction of time the most exposed individual occupies the adjacent area.
Transmission factor (B) — the fraction of unshielded dose that must pass through the barrier to meet the design goal.
Tenth-value layer (TVL) — the thickness of a material that reduces the dose rate to one-tenth; it depends strongly on photon energy.¹²

What radiation sources matter

The principal sources in a conventional nuclear medicine department are:¹⁴

The hot lab: the Mo-99/Tc-99m generator, multidose vials, drawn syringes, and radioactive waste.
The dose-administration area, where activity is injected.
Injected patients in uptake and waiting areas, where they may dwell longer than in the camera room.
Injected patients in the imaging room, acting as distributed 140 keV sources during acquisition.
Restrooms used by injected patients, and decay-in-storage waste.

Because the patient is frequently the dominant and most mobile source, shielding calculations should be organized by room occupancy, source-to-barrier distance, time-integrated activity, and patient throughput — the same source-follows-workflow philosophy used in PET/CT shielding, applied to a much softer photon.¹²

Design goals and occupancy

Shielding is designed to weekly dose goals rather than annual limits directly. A common objective is about 0.02 mGy per week (roughly 1 mSv per year) for uncontrolled areas and about 0.1 mGy per week (roughly 5 mGy per year) for controlled areas, consistent with the design goals and occupancy factors in NCRP Report No. 147 and deliberately more restrictive than the absolute occupational limits in 10 CFR Part 20 to support ALARA.³⁶ Occupancy factors scale the goal to reality: a full-time adjacent office carries an occupancy factor of 1, while corridors, restrooms, and storage rooms carry smaller factors.³

Key Technical Principles

Energy sets the shielding regime

The single most important physical fact in nuclear medicine shielding is how strongly attenuation depends on photon energy. Tc-99m's 140 keV photon is attenuated by lead far more efficiently than PET's 511 keV annihilation photons, and I-131's 364 keV therapy photon sits in between. The table compares the two most common imaging regimes.

Quantity	Tc-99m (140 keV)	F-18 / PET (511 keV)
Principal photon energy	140.5 keV	511 keV (annihilation)
Approx. dose-rate constant, $Γ$	~0.02 µSv·m²·MBq⁻¹·h⁻¹	~0.092 µSv·m²·MBq⁻¹·h⁻¹ (patient)
Approx. lead TVL	~0.9 mm	~16.6 mm
Approx. concrete TVL	a few centimeters	~15–18 cm
Typical barrier outcome	Often met by layout/distance	Frequently needs structural lead

The lead TVL differs by roughly a factor of eighteen between 140 keV and 511 keV, and the dose-rate constant is several times larger for the injected PET patient.¹² Together these explain why a conventional Tc-99m department is so much easier to shield than a PET suite.

The barrier calculation

Following the same framework used for PET, the unshielded dose rate from a source of activity $A$ at distance $d$ is:

\dot{D}_{0} = \frac{Γ \cdot A}{d ^{2}}

The weekly unshielded dose at a design point sums over the time per patient $t$ and the number of patients per week $N$ :

D_{0} = \dot{D}_{0} \cdot t \cdot N

For an occupied point with weekly design goal $P$ and occupancy factor $T$ , the required transmission factor is:

B = \frac{P}{D _{0} \cdot T}

and the required barrier thickness follows from the tenth-value layer at the relevant photon energy:

x = TVL \cdot lo g_{10} (\frac{1}{B})

When decay during a dwell interval is significant, the average activity over that interval can be scaled by the reduction factor $R_{t} = (1 - e^{- λ Δ t}) / (λ Δ t)$ ; for the short imaging intervals of Tc-99m with its 6.0-hour half-life, decay during a single scan is small.¹²

Worked example: a Tc-99m imaging room wall

Consider an uncontrolled office sharing a wall with a gamma camera room in a general nuclear medicine department. Simplified assumptions, mirroring a conservative first-pass estimate:¹²

Radionuclide: Tc-99m; dose-rate constant $Γ \approx 0.02 μ Sv\cdotm^{2} \cdotMBq^{- 1} \cdoth^{- 1}$ .
Approximate average activity in the patient during imaging: 740 MBq (20 mCi), taken conservatively as the administered activity.
Distance from patient to the occupied point beyond the wall: $d = 2$ m.
Time in the camera room per patient: $t = 0.33$ h (about 20 minutes).
Patients per week past this wall: $N = 25$ .
Occupancy factor for the office: $T = 1.0$ .
Weekly design goal (uncontrolled): $P = 20 μ Sv/week$ .

The unshielded dose rate is:

\dot{D}_{0} = \frac{0.02 \times 740}{2 ^{2}} = 3.7 μ Sv/h

The weekly unshielded dose is:

D_{0} = 3.7 \times 0.33 \times 25 \approx 30.5 μ Sv/week

The required transmission factor is:

B = \frac{20}{30.5 \times 1.0} \approx 0.66

and the required lead thickness is:

x_{Pb} = 0.9 mm \times lo g_{10} (\frac{1}{0.66}) \approx 0.9 \times 0.18 \approx 0.16 mm

Only about 0.16 mm of lead is required — a thickness comfortably provided by ordinary construction, so this wall likely needs no added lead at all.¹² Running the same arithmetic for a PET patient (a larger $Γ$ and a 17 mm lead TVL) would demand a barrier one to two orders of magnitude thicker, which is exactly why conventional nuclear medicine and PET are treated as different shielding problems. A complete design would still sum contributions from the hot lab, waiting and uptake areas, and adjacent rooms, evaluate floors and ceilings, and verify with a survey.¹²

Clinical Impact

Shielding decisions shape department layout, patient flow, staff dose, and construction cost — and in conventional nuclear medicine, layout is the most powerful lever. Because 140 keV photons attenuate with distance and modest material, placing high-activity functions (hot lab, injection, uptake) adjacent to low-occupancy spaces — storage, mechanical rooms, circulation — often meets the design goals without lead, whereas forcing those functions next to full-time offices can turn an easy design into one that needs barriers.¹

The injected patient's mobility means occupational dose to technologists is driven as much by workflow as by walls: time near the patient during injection and positioning, and distance maintained afterward, dominate staff exposure. This is why nuclear medicine radiation protection integrates facility shielding with time-distance-shielding work practices rather than relying on barriers alone.⁵ Vertical adjacencies matter too — patients and hot-lab sources expose rooms above and below, so a multistory medical office building must be evaluated in three dimensions, not just in plan view.¹

Finally, the analysis must anticipate service-line change. A department that adds a high-throughput service, a PET/CT line, or an I-131 therapy program changes its source term and may invalidate the original design basis — one reason the shielding report documents its workload and activity assumptions explicitly.¹²

Practical Optimization Tips

Zone the department before adding lead

Place hot lab, injection, and uptake areas against low-occupancy neighbors, and keep full-time occupied spaces at distance. Distance is free and works on the inverse-square law; lead is expensive and added late. Good adjacency planning is the highest-yield shielding decision in a conventional department.¹

Use realistic, documented workload

Barrier requirements scale with administered activity, time per patient, and patients per week. Use realistic, service-specific throughput rather than worst-case guesses, and document the assumptions so the design can be re-evaluated when volume grows.¹²

Treat the hot lab and therapy rooms as their own problems

The hot lab concentrates the generator, vials, and waste; it typically uses local shielding (L-blocks, syringe and vial shields, a shielded generator, and a shielded waste store) rather than relying on room barriers. Inpatient I-131 therapy rooms are a separate, more demanding design because I-131's 364 keV photon has a larger tenth-value layer and therapy activities and dwell times are high.¹⁵ For the source-preparation environment, see our guide to nuclear medicine hot lab design.

Choose materials sensibly

For the soft 140 keV photon, ordinary construction and modest lead go a long way; the material-selection logic is the same as in general lead shielding design, scaled to a lower energy. The framework carries directly over from diagnostic x-ray room shielding under NCRP 147, with the source changed from an x-ray beam to a distributed radionuclide.¹³

Verify the installed condition

A shielding design is not complete until a post-construction radiation survey confirms that measured dose rates, scaled to realistic workload and occupancy, meet the design goals. Choose an energy-appropriate, calibrated instrument for the survey; see our guidance on choosing the right radiation survey meter.¹³

Regulatory Considerations

Nuclear medicine shielding sits under NRC or Agreement State materials regulation, because the sources are unsealed byproduct material rather than radiation-producing machines. The framework includes:

Materials regulation. Possession and medical use of Tc-99m, I-131, and other byproduct material fall under 10 CFR Part 35 (or the equivalent Agreement State program), with public- and occupational-dose limits set by 10 CFR Part 20. NRC program-specific licensing guidance, NUREG-1556 Volume 9, addresses facility and shielding adequacy expectations.⁶⁷⁸
Shielding methodology. The design goals and occupancy framework of NCRP Report No. 147, the gamma-shielding methodology of NCRP Report No. 49, and radionuclide-specific dose-rate constants and transmission data for nuclear medicine facilities provide the technical basis for the calculations.¹³⁹
State rules. Many states require a qualified or board-certified medical physicist's shielding report before a nuclear medicine facility is approved for clinical use. In Florida, materials use is administered under Florida Administrative Code Chapter 64E-5; DRPS also serves Maryland, Virginia, Washington DC, California, Nevada, Pennsylvania, New York, New Jersey, and Delaware, where Agreement State or NRC authorities impose parallel expectations. Washington DC and Delaware are directly regulated by the NRC for radioactive material. Always confirm requirements with the authority having jurisdiction.

A defensible package documents the radionuclides and activities, patient throughput and dwell times, occupancy factors, barrier materials and thicknesses, drawing references, survey results, and a physicist certification where required.¹³⁸

Frequently Asked Questions (FAQs)

Does a conventional nuclear medicine department need lead-lined walls like a PET suite?

Usually far less, and often none. Tc-99m's 140 keV photons are much less penetrating than PET's 511 keV photons — the lead tenth-value layer is roughly 0.9 mm versus about 17 mm — so equivalent performance needs far less lead, and layout and distance often meet the design goals.¹²

What design goals are used?

About 0.02 mGy per week (≈1 mSv per year) for uncontrolled areas and about 0.1 mGy per week (≈5 mGy per year) for controlled areas, consistent with NCRP Report No. 147 and more restrictive than the 10 CFR Part 20 limits.³⁶

What are the main radiation sources?

The injected patient (a distributed source), the hot lab (generator, vials, syringes, waste), the injection and uptake areas, imaging rooms, restrooms used by patients, and decay-in-storage waste.¹⁴

How is the required barrier thickness calculated?

Estimate the unshielded weekly dose from the dose-rate constant, activity, distance, time, and patient count; the required transmission factor is the design goal divided by the product of unshielded dose and occupancy; the thickness follows from the tenth-value layer at the photon energy.¹²

Why does I-131 therapy need more shielding?

I-131 emits a higher-energy 364 keV photon (larger tenth-value layer) and is given at high therapy activities with long room dwell times, so both energy and time-integrated activity raise barrier requirements. Therapy rooms are designed as a separate, more demanding problem.¹⁵

Key Takeaways

Conventional nuclear medicine shielding is dominated by the injected patient as a distributed 140 keV source, so it is organized by workflow, occupancy, distance, and activity.¹⁴
Tc-99m's soft 140 keV photon attenuates far more efficiently than PET's 511 keV photons — a lead TVL of roughly 0.9 mm versus about 17 mm — so conventional rooms often need little or no structural lead.¹²
Design to weekly goals of about 0.02 mGy/week (uncontrolled) and 0.1 mGy/week (controlled), consistent with NCRP Report No. 147 and stricter than 10 CFR Part 20 limits.³⁶
A worked barrier calculation for a typical Tc-99m camera-room wall yields only a fraction of a millimeter of required lead, which ordinary construction provides.¹²
The hot lab uses local shielding, and I-131 therapy rooms are a separate, more demanding design because of the 364 keV photon and high activities.¹⁵
A design is not complete until a post-construction survey verifies the installed barriers against the design goals.¹³

How DRPS Can Help

Diagnostic Radiation Physics Services (DRPS) supports nuclear medicine facilities across Florida, Maryland, Virginia, Washington DC, California, Nevada, Pennsylvania, New York, New Jersey, and Delaware with radiation shielding design, architectural plan review, workload and adjacency modeling, hot lab and therapy-room evaluation, post-construction shielding surveys, and radiation safety documentation prepared by board-certified medical physicists.

Our nuclear medicine physics and medical physicist consulting teams can help design a department that meets its dose goals economically — using layout and distance first and lead only where it is needed — and can verify the result before the first patient is imaged. To discuss a shielding design or survey, contact DRPS.

Conclusion

Shielding a conventional nuclear medicine department is, at its core, an exercise in following the radiopharmaceutical through the facility and letting physics do the work. Because Tc-99m's 140 keV photon is so much softer than PET's 511 keV annihilation photons, distance and layout usually carry the load, and lead is reserved for the hot lab, specific adjacencies, and the more demanding I-131 therapy room. A design that estimates unshielded dose from realistic workload, compares it to weekly design goals, applies the correct tenth-value layer, and verifies the installed condition with a survey will protect adjacent occupied areas while keeping the facility efficient and adaptable.¹²³

Related Resources

References

Kusano M, Caldwell CB. Dose equivalent rate constants and barrier transmission data for nuclear medicine facility dose calculations and shielding design. Health Phys. 2014;107(1):60-72. doi:10.1097/HP.0000000000000051. doi.org
Madsen MT, Anderson JA, Halama JR, et al. AAPM Task Group 108: PET and PET/CT shielding requirements. Med Phys. 2006;33(1):4-15. doi:10.1118/1.2135911. doi.org
National Council on Radiation Protection and Measurements. Structural Shielding Design for Medical X-Ray Imaging Facilities. NCRP Report No. 147. Bethesda, MD: NCRP; 2004. ncrponline.org
National Council on Radiation Protection and Measurements. Structural Shielding Design and Evaluation for Medical Use of X Rays and Gamma Rays of Energies Up to 10 MeV. NCRP Report No. 49. Bethesda, MD: NCRP; 1976. ncrponline.org
Zanzonico P, Dauer L, St Germain J. Operational radiation safety for PET-CT, SPECT-CT, and cyclotron facilities. Health Phys. 2008;95(5):554-570. doi:10.1097/01.HP.0000327651.15794.f7. doi.org
U.S. Nuclear Regulatory Commission. 10 CFR Part 20, Standards for Protection Against Radiation. nrc.gov
U.S. Nuclear Regulatory Commission. 10 CFR Part 35, Medical Use of Byproduct Material. nrc.gov
U.S. Nuclear Regulatory Commission. Consolidated Guidance About Materials Licenses: Program-Specific Guidance About Medical Use Licenses. NUREG-1556, Volume 9. nrc.gov
National Institute of Standards and Technology. Radionuclide Half-Life Measurements and Decay Data (technetium-99m, iodine-131). nist.gov